IL255182B2 - History of Korormicn with use as an antibiotic - Google Patents
History of Korormicn with use as an antibioticInfo
- Publication number
- IL255182B2 IL255182B2 IL255182A IL25518217A IL255182B2 IL 255182 B2 IL255182 B2 IL 255182B2 IL 255182 A IL255182 A IL 255182A IL 25518217 A IL25518217 A IL 25518217A IL 255182 B2 IL255182 B2 IL 255182B2
- Authority
- IL
- Israel
- Prior art keywords
- compound
- peg
- vibrio
- nqr
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562151902P | 2015-04-23 | 2015-04-23 | |
| PCT/CA2016/050470 WO2016168938A1 (en) | 2015-04-23 | 2016-04-22 | Derivatives of korormicin useful as antibiotics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL255182A0 IL255182A0 (en) | 2017-12-31 |
| IL255182B1 IL255182B1 (en) | 2024-02-01 |
| IL255182B2 true IL255182B2 (en) | 2024-06-01 |
Family
ID=57142747
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL255182A IL255182B2 (en) | 2015-04-23 | 2016-04-22 | History of Korormicn with use as an antibiotic |
| IL310102A IL310102A (en) | 2015-04-23 | 2016-04-22 | History of Korormicn with use as an antibiotic |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310102A IL310102A (en) | 2015-04-23 | 2016-04-22 | History of Korormicn with use as an antibiotic |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10166213B2 (enExample) |
| EP (1) | EP3285762A4 (enExample) |
| JP (3) | JP6842089B2 (enExample) |
| CN (2) | CN107708689A (enExample) |
| AU (4) | AU2016253429B2 (enExample) |
| CA (1) | CA2983460A1 (enExample) |
| IL (2) | IL255182B2 (enExample) |
| WO (1) | WO2016168938A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107708689A (zh) * | 2015-04-23 | 2018-02-16 | 帕维尔·迪布韦 | 用作抗生素的Korormicin衍生物 |
| CN116617231B (zh) * | 2023-06-12 | 2024-11-15 | 沈阳药科大学 | 2-氨基萘嵌间二氮杂苯氢溴化物增强对革兰氏阴性菌杀菌作用的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2315489A (en) * | 1996-07-17 | 1998-02-04 | Merck & Co Inc | Antifungal agent |
| JP3905604B2 (ja) | 1997-03-04 | 2007-04-18 | 株式会社海洋バイオテクノロジー研究所 | 新規化学物質コロールミシン |
| JP2000281670A (ja) | 1999-03-26 | 2000-10-10 | Marine Biotechnol Inst Co Ltd | 新規コロールミシン合成中間体及び製造法 |
| JP2000336088A (ja) * | 1999-05-27 | 2000-12-05 | Marine Biotechnol Inst Co Ltd | 新規化学物質Ｆ４２０ｍ類縁体 |
| JP2001010908A (ja) * | 1999-06-28 | 2001-01-16 | Marine Biotechnol Inst Co Ltd | 防汚剤 |
| JP2003061645A (ja) | 2001-08-23 | 2003-03-04 | Marine Biotechnol Inst Co Ltd | 海洋細菌の選択培地 |
| US7910622B2 (en) * | 2007-03-19 | 2011-03-22 | Wisconsin Alumni Research Foundation | Modulation of bacterial quorum sensing with synthetic ligands |
| CN102482244B (zh) * | 2009-07-03 | 2015-09-09 | 内盖夫国家生物技术有限公司 | 细菌群体感应的共价抑制 |
| CN107708689A (zh) * | 2015-04-23 | 2018-02-16 | 帕维尔·迪布韦 | 用作抗生素的Korormicin衍生物 |
-
2016
- 2016-04-22 CN CN201680033925.3A patent/CN107708689A/zh active Pending
- 2016-04-22 IL IL255182A patent/IL255182B2/en unknown
- 2016-04-22 EP EP16782435.8A patent/EP3285762A4/en not_active Ceased
- 2016-04-22 JP JP2017555587A patent/JP6842089B2/ja active Active
- 2016-04-22 CA CA2983460A patent/CA2983460A1/en active Pending
- 2016-04-22 IL IL310102A patent/IL310102A/en unknown
- 2016-04-22 WO PCT/CA2016/050470 patent/WO2016168938A1/en not_active Ceased
- 2016-04-22 CN CN202310483500.4A patent/CN116574132A/zh active Pending
- 2016-04-22 AU AU2016253429A patent/AU2016253429B2/en not_active Ceased
- 2016-04-22 US US15/500,006 patent/US10166213B2/en active Active
-
2018
- 2018-11-15 US US16/192,117 patent/US10744111B2/en active Active
-
2019
- 2019-04-02 AU AU2019202254A patent/AU2019202254B2/en not_active Ceased
-
2020
- 2020-07-15 US US16/930,178 patent/US11324716B2/en active Active
- 2020-11-11 AU AU2020267205A patent/AU2020267205B2/en not_active Ceased
-
2021
- 2021-02-03 JP JP2021015712A patent/JP7121225B2/ja active Active
-
2022
- 2022-03-02 JP JP2022032136A patent/JP2022122857A/ja active Pending
- 2022-04-27 US US17/660,886 patent/US12029716B2/en active Active
- 2022-07-08 AU AU2022204906A patent/AU2022204906B2/en not_active Ceased
-
2024
- 2024-07-08 US US18/766,386 patent/US20240358670A1/en active Pending
Non-Patent Citations (4)
| Title |
|---|
| KOBAYASHI ET AL., TOTAL SYNTHESIS OF KORORMICIN, 31 May 2001 (2001-05-31) * |
| TEBBEN ET AL., A CORALLINE ALGAL-ASSOCIATED BACTERIUM, PSEUDOALTEROMONAS STRAIN J010, YIELDS FIVE NEW KORORMICINS AND A BROMOPYRROLE, 13 May 2014 (2014-05-13) * |
| YOSHIKAWA ET AL, PLANAR STRUCTURE AND ANTIBACTERIAL ACTIVITY OF KOROMICIN DERIVATIVES ISOLATED FROM PSEUDOALTEROMONAS SP., 31 October 2003 (2003-10-31) * |
| YOSHIKAWA ET AL., KORORMICIN, A NOVEL ANTIBIOTIC SPECIFICALLY ACTIVE AGAINST MARINE GRAM-NEGATIVE BACTERIA, PRODUCED BY A MARINE BACTERIUM., 30 November 1997 (1997-11-30) * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019202254A1 (en) | 2019-05-02 |
| JP2018513194A (ja) | 2018-05-24 |
| AU2016253429B2 (en) | 2019-01-03 |
| CN116574132A (zh) | 2023-08-11 |
| AU2022204906A1 (en) | 2022-07-28 |
| AU2020267205A1 (en) | 2020-12-10 |
| CA2983460A1 (en) | 2016-10-27 |
| JP2021073278A (ja) | 2021-05-13 |
| WO2016168938A1 (en) | 2016-10-27 |
| US20190083450A1 (en) | 2019-03-21 |
| JP7121225B2 (ja) | 2022-08-18 |
| EP3285762A1 (en) | 2018-02-28 |
| US20240358670A1 (en) | 2024-10-31 |
| US20220257555A1 (en) | 2022-08-18 |
| AU2022204906B2 (en) | 2024-03-28 |
| US10744111B2 (en) | 2020-08-18 |
| US12029716B2 (en) | 2024-07-09 |
| AU2019202254B2 (en) | 2020-08-13 |
| IL255182B1 (en) | 2024-02-01 |
| US20200345682A1 (en) | 2020-11-05 |
| AU2020267205B2 (en) | 2022-04-14 |
| AU2016253429A1 (en) | 2017-12-07 |
| US11324716B2 (en) | 2022-05-10 |
| JP2022122857A (ja) | 2022-08-23 |
| EP3285762A4 (en) | 2019-02-06 |
| US20180064680A1 (en) | 2018-03-08 |
| US10166213B2 (en) | 2019-01-01 |
| JP6842089B2 (ja) | 2021-03-17 |
| IL310102A (en) | 2024-03-01 |
| CN107708689A (zh) | 2018-02-16 |
| IL255182A0 (en) | 2017-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240358670A1 (en) | Derivatives of korormicin useful as antibiotics | |
| Poelarends et al. | Multidrug transporters and antibiotic resistance in Lactococcus lactis | |
| Wu et al. | Bacillomycin D effectively controls growth of Malassezia globosa by disrupting the cell membrane | |
| US8748661B2 (en) | Polyamino polyketide antibiotics and uses thereof | |
| KR100251888B1 (ko) | 긴 사슬의 지방족 알콜을 가진 아실카르니틴 에스테르와 항박테리아 활성을 지닌 그의 약제조성물 | |
| Ohsuka et al. | Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways | |
| US20030147930A1 (en) | Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives | |
| CA2413284A1 (fr) | Utilisation d'acides en c4-c10 pour la prevention des infections a bacteries a gram negatif | |
| JP2007521239A (ja) | 抗菌組成物及び使用方法 | |
| Wang et al. | Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii | |
| US4459307A (en) | Antibacterial drug | |
| HK40087860A (zh) | Capsaicyns在治疗肠漏中的应用 | |
| Dibrov | Searching for New Antimicrobial Targets: Na+ Cycle in Energetics of Bacterial Pathogens | |
| US20240009150A1 (en) | Capsaicyns in the treatment of leaky gut | |
| CN119837893A (zh) | 5-氟-2′-脱氧胞苷在制备抗菌药物中的用途 | |
| Osborne | Antimicrobials and antimicrobial resistance: two studies investigating different ways to tackle the issue | |
| Machado | The Inhibitory Activity of Synthetic Compounds and Ions Against Transporters of Multi-drug Resistant Bacteria |